UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A new central scaffold for metastasis : Parsing HEF1/Cas-L/NEDD9

Cancer research (Chicago, Ill.), 2007-10, Vol.67 (19), p.8975-8979

2007

Volltextzugriff (PDF)

IKKβ and NF-κB Transcription Govern Lymphoma Cell Survival through AKT-Induced Plasma Membrane Trafficking of GLUT1

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (23), p.7291-7300

2011

Volltextzugriff (PDF)

Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer

Cancer research (Chicago, Ill.), 1995-06, Vol.55 (12), p.2556-2559

1995

Volltextzugriff (PDF)

Abstract P4-13-02: Selective androgen receptor modulator RAD140 inhibits the growth of endocrine-resistant breast cancer models with defined genetic backgrounds

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P4-P4-13-02

2019

Volltextzugriff (PDF)

Abstract 5692: Low frequency electromagnetic field suppresses macrophage phagocytosis

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5692-5692

2018

Volltextzugriff (PDF)

Abstract CT165: A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT165-CT165

2021

Volltextzugriff (PDF)

Abstract 5160: Identifying TK1 localization in immortalized placental cell lines and in conditioned placental tissue

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5160-5160

2018

Volltextzugriff (PDF)

Abstract OT1-02-02: A phase 1, first-in-human, multi-part study of RAD140, an oral nonsteroidal selective androgen receptor modulator, in postmenopausal women with hormone receptor positive breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.OT1-02-02-OT1-02-02

2019

Volltextzugriff (PDF)

Abstract 1239: The expression of salvage pathway enzymes in non-small cell lung cancer cells

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1239-1239

2017

Volltextzugriff (PDF)

Abstract 5619: Development of a TK1 specific chimeric antigen receptor T-cell for the treatment of non-small-cell lung cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5619-5619

2017

Volltextzugriff (PDF)

Abstract 771: HPRT: A biomarker and potential target for detection and treatment of colorectal cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.771-771

2018

Volltextzugriff (PDF)

Loss of Rassf1a Synergizes with Deregulated Runx2 Signaling in Tumorigenesis

Cancer research (Chicago, Ill.), 2012-08, Vol.72 (15), p.3817-3827

2012

Volltextzugriff (PDF)

Abstract P2-08-06: A phase 1 study of RAD1901, a novel, oral selective estrogen receptor degrader, for the treatment of ER-positive advanced breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-08-06

2017

Volltextzugriff (PDF)

Abstract B008: The role of the androgen receptor in reciprocal activation of breast cancer metastases and the lung epithelium during metastatic outgrowth

Cancer research (Chicago, Ill.), 2023-01, Vol.83 (2_Supplement_2), p.B008-B008

2023

Volltextzugriff (PDF)

Abstract GS6-03: Circulating tumor cells (CTCs) five years after diagnosis are prognostic for late recurrence in operable stage II-III breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.GS6-03-GS6-03

2018

Volltextzugriff (PDF)

Abstract GS6-05: The impact of breast cancer surgery on quality of life: Long term results from E5103

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.GS6-05-GS6-05

2019

Volltextzugriff (PDF)

Abstract 3353: Prostate cancer microenvironment modulates macrophage phagocytosis

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3353-3353

2015

Volltextzugriff (PDF)

Abstract 2149: Unusual expression of HPRT on the surface of the colorectal cancer cell lines HT29 and SW620

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2149-2149

2017

Volltextzugriff (PDF)

Abstract 2563: Macrophage Toll-like receptor-chimeric antigen receptors (MOTO-CARs) as a novel adoptive cell therapy for the treatment of solid malignancies

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2563-2563

2018

Volltextzugriff (PDF)

Abstract CT112: A Phase I multicenter trial of the dual MDM2/MDMX inhibitor ALRN-6924 in children and young adults with relapsed/refractory pediatric cancers

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.CT112-CT112

2019

Volltextzugriff (PDF)

Abstract 3355: Are cancer cells redefining macrophages’ aggressiveness

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3355-3355

2015

Volltextzugriff (PDF)

Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl :protein transferase inhibitor

Cancer research (Chicago, Ill.), 2000-05, Vol.60 (10), p.2680-2688

2000

Volltextzugriff (PDF)

Abstract 1657: How does the tumor microenvironment affect macrophage aggressiveness

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1657-1657

2014

Volltextzugriff (PDF)

Small molecule antagonists of the σ-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo

Cancer research (Chicago, Ill.), 2004-07, Vol.64 (14), p.4875-4886

2004

Volltextzugriff (PDF)

Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells

Cancer research (Chicago, Ill.), 2008-11, Vol.68 (22), p.9441-9450

2008

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

ThemaAged

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(10)
Humans
(10)
Medical Sciences
(10)
Antineoplastic Agents
(9)
Pharmacology. Drug Treatments
(9)
Life Sciences & Biomedicine
(8)
Oncology
(8)
Science & Technology
(8)
Animals
(6)
Tumors
(5)
Male
(4)
Female
(3)
General Aspects
(3)
Mice
(3)
Caspases - Metabolism
(2)
Cells, Cultured
(2)
Chemotherapy
(2)
Gene Expression Regulation, Neoplastic
(2)
Injections, Intravenous
(2)
Kinetics
(2)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

A new central scaffold for metastasis : Parsing HEF1/Cas-L/NEDD9

IKKβ and NF-κB Transcription Govern Lymphoma Cell Survival through AKT-Induced Plasma Membrane Trafficking of GLUT1

Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer

Abstract P4-13-02: Selective androgen receptor modulator RAD140 inhibits the growth of endocrine-resistant breast cancer models with defined genetic backgrounds

Abstract 5692: Low frequency electromagnetic field suppresses macrophage phagocytosis

Abstract CT165: A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma

Abstract 5160: Identifying TK1 localization in immortalized placental cell lines and in conditioned placental tissue

Abstract OT1-02-02: A phase 1, first-in-human, multi-part study of RAD140, an oral nonsteroidal selective androgen receptor modulator, in postmenopausal women with hormone receptor positive breast cancer

Abstract 1239: The expression of salvage pathway enzymes in non-small cell lung cancer cells

Abstract 5619: Development of a TK1 specific chimeric antigen receptor T-cell for the treatment of non-small-cell lung cancer

Abstract 771: HPRT: A biomarker and potential target for detection and treatment of colorectal cancer

Loss of Rassf1a Synergizes with Deregulated Runx2 Signaling in Tumorigenesis

Abstract P2-08-06: A phase 1 study of RAD1901, a novel, oral selective estrogen receptor degrader, for the treatment of ER-positive advanced breast cancer

Abstract B008: The role of the androgen receptor in reciprocal activation of breast cancer metastases and the lung epithelium during metastatic outgrowth

Abstract GS6-03: Circulating tumor cells (CTCs) five years after diagnosis are prognostic for late recurrence in operable stage II-III breast cancer

Abstract GS6-05: The impact of breast cancer surgery on quality of life: Long term results from E5103

Abstract 3353: Prostate cancer microenvironment modulates macrophage phagocytosis

Abstract 2149: Unusual expression of HPRT on the surface of the colorectal cancer cell lines HT29 and SW620

Abstract 2563: Macrophage Toll-like receptor-chimeric antigen receptors (MOTO-CARs) as a novel adoptive cell therapy for the treatment of solid malignancies

Abstract CT112: A Phase I multicenter trial of the dual MDM2/MDMX inhibitor ALRN-6924 in children and young adults with relapsed/refractory pediatric cancers

Abstract 3355: Are cancer cells redefining macrophages’ aggressiveness

Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl :protein transferase inhibitor

Abstract 1657: How does the tumor microenvironment affect macrophage aggressiveness

Small molecule antagonists of the σ-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo

Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells

Aktive Filter

Suchergebnisse filtern